연구성과로 돌아가기

2025 연구자 정보 (26 / 657)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Ko, Yunmi
(Ko, Y)
Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea


[JCR상위 1.7] AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B SCIE 1.7 GASTROENTEROLOGY & HEPATOLOGY pindra@empal.com;
Kwong, Ava
(Kwong, A)


[JCR상위 1.7] Real-time AI-based computer-aided detection/diagnosis (AI-CAD) for breast ultrasound: A prospective, multicenter, multinational study. SCIE 1.7 ONCOLOGY
Lee, Dong Ho
(Lee, DH)
Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea
Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam Si, South Korea


[JCR상위 1.7] AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B
[JCR상위 54.1] A Phase 2, Multi-Center, Randomized, Double-Blind, Parallel-Group Trial to Evaluate the Efficacy and Safety of CKD-495 in Patients With Acute and Chronic Gastritis
SCIE 1.7 GASTROENTEROLOGY & HEPATOLOGY pindra@empal.com;
leeoy@hanyang.ac.kr;
Lee, Han Ah
(Lee, HA)
Chung Ang Univ, Coll Med, Dept Internal Med, Seoul, South Korea

[JCR상위 1.7] AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B SCIE 1.7 GASTROENTEROLOGY & HEPATOLOGY pindra@empal.com;
Lee, Hyung-Chul
(Lee, HC)
Seoul Natl Univ, Coll Med, Dept Anesthesiol, Seoul, South Korea

[JCR상위 1.7] AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B SCIE 1.7 GASTROENTEROLOGY & HEPATOLOGY pindra@empal.com;
Lee, In Hee
(Lee, IH)
Daegu Catholic Univ, Sch Med, Dept Internal Med, Daegu, South Korea

[JCR상위 1.7] Real-time AI-based computer-aided detection/diagnosis (AI-CAD) for breast ultrasound: A prospective, multicenter, multinational study.
[JCR상위 31.8] Comparison of Urinary Red Blood Cell Distribution (URD) and Dysmorphic Red Blood Cells for Detecting Glomerular Hematuria: A Multicenter Study
[JCR상위 1.7] Role of EMP2 in triple-negative breast cancer.
[JCR상위 1.7] Predicting high-risk group according to Oncotype DX recurrence score using dynamic contrast-enhanced breast MR with temporal radiomic features.
SCIE 1.7 ONCOLOGY
MEDICAL LABORATORY TECHNOLOGY
chjeon@cu.ac.kr;
Lee, Jeeyeon Elizabeth
(Lee, JE)
제1저자

[JCR상위 1.7] Real-time AI-based computer-aided detection/diagnosis (AI-CAD) for breast ultrasound: A prospective, multicenter, multinational study.
[JCR상위 1.7] Role of EMP2 in triple-negative breast cancer.
[JCR상위 1.7] Predicting high-risk group according to Oncotype DX recurrence score using dynamic contrast-enhanced breast MR with temporal radiomic features.
SCIE 1.7 ONCOLOGY
Lee, Jeong-Hoon
(Lee, JH)
교신저자 Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea
Inocras Inc, San Diego, CA USA
Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Seoul, South Korea


[JCR상위 1.7] AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B
[JCR상위 1.0] Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial
SCIE 1.0 GASTROENTEROLOGY & HEPATOLOGY pindra@empal.com;
limys@amc.seoul.kr;
Lee, Jieun
(Lee, J)
Samsung Elect, DRAM Yield Enhancement Team, Mfg & Proc Technol, Suwon 18448, Gyeonggi Do, South Korea

[JCR상위 1.7] Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial.
[JCR상위 73.5] Gate oxide technology relieving word-line break in 10 nm-class DRAMs
SCIE 1.7 ONCOLOGY
PHYSICS, APPLIED
yhong@pusan.ac.kr;
Lee, Keun Seok
(Lee, KS)


[JCR상위 1.7] Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. SCIE 1.7 ONCOLOGY
Lee, Kyung-Hun
(Lee, KH)


[JCR상위 1.7] Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. SCIE 1.7 ONCOLOGY
Lee, Soo Jung
(Lee, SJ)


[JCR상위 1.7] Real-time AI-based computer-aided detection/diagnosis (AI-CAD) for breast ultrasound: A prospective, multicenter, multinational study.
[JCR상위 1.7] Role of EMP2 in triple-negative breast cancer.
[JCR상위 1.7] Predicting high-risk group according to Oncotype DX recurrence score using dynamic contrast-enhanced breast MR with temporal radiomic features.
SCIE 1.7 ONCOLOGY
Lee, Suee
(Lee, S)


[JCR상위 1.7] Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. SCIE 1.7 ONCOLOGY
Lim, Seungtaek
(Lim, S)


[JCR상위 1.7] Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. SCIE 1.7 ONCOLOGY
Lin, Bingliang
(Lin, BL)
Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou, Peoples R China

[JCR상위 1.7] Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study SCIE 1.7 GASTROENTEROLOGY & HEPATOLOGY jia_jd@ccmu.edu.cn;
페이지 이동: